Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors

Journal of Urban Health

Volumn 81, Issue 2, 2004, Pages 249-259

  Riehman, Kara S ^a,e   Kral, Alex H ^b   Anderson, Rachel ^c   Flynn, Neil ^c   Bluthenthal, Ricky N ^d  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DREW UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEXUALITY; SYRINGE; UNITED STATES;

EID: 3042533557     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jth111     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 2001. HIV AIDS Surveill Rep. 2001;13(2). Available at: www.cdc.gov/hiv/stats/hasr1302.htm. Accessed January 6, 2003.
2. Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. 2002. Available at: www.cdc.gov/hiv/pubs/facts/idu.htm. Accessed January 6, 2003.
3. Booth RE. Gender differences in high-risk sex behaviors among heterosexual drug injectors and crack smokers. Am J Drug Alcohol Abuse. 1995;21:419-432.
4. Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco. J Urban Health. 2003;80:137-146.
5. Geoghegan T, O'Shea M, Cox G. Gender differences in characteristics of drug users presenting to a Dublin syringe exchange. Ir J Psychol Med. 1999;16:131-135.
6. Riehman K, Iguchi M, Morral A, Zeller M. The influence of partner drug use and relationship power on treatment engagement. Drug Alcohol Depend. 2003;70:1-10.
7. Wechsberg WM, Rounds-Bryant J, Zhang Y. HIV Risk Behaviors by gender and ethnicity among substance abusers entering treatment. J Maintenance Addict. 2003;2:37-63.
8. Wechsberg WM, Dennis MS, Ying Z. Women and men injectors: differences and trends in their drug use patterns and HIV risk. Paper presented at: meeting of the American Public Health Association; November 1995; San Diego, CA.
9. Wechsberg WM & Cavanaugh ER. Differences found between women in and out of treatment: Implications for interventions." Drugs Soc. 1998;13:65-82.
10. Bluthenthal RN, Kral AH, Erringer, EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992-1995. J Acquir Immune Defic Syndr. 1998;18:505-511.
11. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS. 2000;14:605-611.
12. Gibson DR, Brand R, Anderson KT, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002;31:237-242.
13. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77:369-382.
14. Paone D, Des Jarlais DC, Shi Q. Syringe exchange use and HIV risk reduction over time [letter]. AIDS. 1998;12:121-123.
15. Robles RR, Colon HM, Matos TD, et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico. Health Policy. 1998;45:209-220.
16. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr. 1997;16:400-406.
17. Des Jarlais DC, Marmor M, Paone D, et al. HIV risk behavior and seroincidence among injection drug users in New York City. Lancet. 1996;348:987-981.
18. Miller M, Eskild A, Mella I, Moi H, Magnus P. Gender differences in syringe exchange program use in Oslo, Norway. Addiction. 2001;96:1639-1651.
19. Valente TW, Foreman RK, Junge B, Vlahov D. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health. 2001;78:340-349.
20. Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS. 1996;10:1729-1734.
21. Des Jarlais DC, McKnight C, Eigo K, Friedmann P. 2000 United States Syringe Exchange Program Survey. North American Syringe Exchange Convention XII; April 24, 2002; Albuquerque, NM.
22. Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for serodiagnosis of HIV type 1 infections. MMWR Morb Mortal Wkly Rep. 1989;37(S-7).
23. Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immune Defic Syndr. 1998;17:160-166.
24. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr. 1997;15:157-164.
25. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;33:199-205.
26. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115-120.
27. Huang KHC, Watters JK, Case P. Psychological assessment and AIDS research with intravenous drug users: challenges in measurement. J Psycboactive Drugs. 1988;20: 191-195.
28. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1: 383-92.
29. Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use [letter]. JAMA. 1992;268:2374-2375.
30. Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Eval Program Plan. 1994;17:347-355.
31. Centers for Disease Control and Prevention. Syringe Exchange Program-United States, 1994-1995. Morbidity and Mortality Weekly Report. 1995;44:684-685.
32. Centers for Disease Control and Prevention. Update: Syringe Exchange Programs-United States, 1998. Morbidity and Mortality Weekly Report. 2001;50(19):384-387.
33. Heimer R, Bluthenthal RN, Singer M, Khoshnood K. Structural impediments to operational syringe-exchange programs. AIDS and Public Policy Journal. 1996;11:169-184.
34. Bluthenthal RN, Malik R, Grau LE, Singer M, Marshal PA, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. In press.
35. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injections risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J AIDS. In press.